ALL Flashcards
▪ Acute Lymphoblastic Leukemia
ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
▪ uncontrolled growth of abnormal lymphoid cells in the
spleen, bone marrow, and lymph nodes
Proliferation of abnormal lymphoid lineage in the bm
ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
▪ DEFECT:
DNA synthesis of lymphoblasts
• not defective but longer than normal tissues (?)
> 1hour
▪ ALL: primarily a disease of
childhood and adolescence
• accounting for [?] of childhood cancers and up to [?] of childhood leukemia (peak is at [?)
25%
75%
2 years of age
• most common:
children between 2-10 years old
uncontrolled growth of abnormal lymphoid cells in the bm = abnormal infiltration of cells in:
bm, spleen, liver, lymph nodes
▪ same with other acute leukemias (weight loss, night sweats/malaise) but
onset is more sudden
: due to proliferation of lymph. in the bm, other blood cells are not produced
▪ cytopenia
: enlargement of spleen and liver presses on the nerves (not common in AML)
▪ cranial nerve paralysis
▪ splenomegaly, hepatomegaly, and enlargement of the
superficial lymph nodes
▪ common causes of death:
- infection
- bleeding (spontaneous)
: lymph. produced are not stimulated by any microbes; no antigenic stimuli; nonreactive
- infection
- bleeding (spontaneous): due to [?]; leukemic cells infiltrates the: [?]
low platelet count (< 50 x 109 /L) or lower at (< 20 x 109 /L)
spleen and liver affecting Vit K dependent factors (↓: II, VII, IX, X)
▪ common causes of infections:
• S. aureus
• P. aeruginosa
• C. albicans
• H. influenza
• P. mirabilis
▪ WBC count:
• vary from low (< 5.0 x 109 /L) to high (> 100 x 109/L)
▪ predominant circulating cell:
leukemic lymphoid blast or lymphoblast
• except in conditions of [?] (has few or no circulating lymphoblasts)
aleukemic leukemia
▪ bone marrow:
• hypercellular (> 100 x 109/L WBC ct)
• heavily infiltrated with lymphoid cells
• presence of fibrosis (abnormal infiltration of lymphocytes in the bm causing bone pain)
B CELL ALL General criteria:
> 25% lymphoblast in BM is identified as Blineage lymphocytes
: equivalent to L1 and L2
▪ B-ALL & B-LBL
B CELL ALL morphology not mentioned by FAB
• lymphoblast with pseudopod projections often seen
▪ criteria: > 25% lymphoblasts in BM
A) Precursor B-lymphoblastic Leukemia (B-ALL)
▪ present in childhood (poor prognosis in adults)
B ALL
B LBL
T ALL
T LBL
A) Precursor B-lymphoblastic Leukemia (B-ALL)
▪ criteria: > 25% lymphoblasts in BM extranodal sites (lymph nodes and spleen; mass lession)
B) B-lymphoblastic Lymphoma (B-LBL)
▪ involvement of lymph nodes which exhibits more mass lesions (less leukemic process)
B) B-lymphoblastic Lymphoma (B-LBL)
▪ rare
B ALL or B LBL
B) B-lymphoblastic Lymphoma (B-LBL)
T CELL ALL general criteria:
> 25% lymphoblast in BM identified as B-lineage lymphocytes
▪ present in children (15-20%) and adults (25%)
A) Precursor T-lymphoblastic Leukemia (T-ALL)
▪ more mitotic blast cell
A) Precursor T-lymphoblastic Leukemia (T-ALL)
▪ frequently found in males in all ages, predominantly in adults
B) T-lymphoblastic Lymphoma (B-LBL)
BASIS OF FAB
▪ cytologic features
▪ degree of heterogeneity in distribution among the leukemic cell population (age)
▪ cytologic features:
cell size, chromatin, nuclear shape, nucleoli, degree of basophilia in the cytoplasm, and presence of cytoplasmic vacuolation
▪ Cell size: small
L1
▪ Cell size: homogenous
L1
L3
▪ Cell size: large
L2
L3
▪ Cell size: heterogenous
L2
NON-B
L1
L2
BURKITT TYPE
L3
▪ Nucleus: regular
L1
L3
▪ Nucleus: occasional clefting
L1
▪ Nucleus: irregular
L2
▪ Nucleus: common clefting or indentation
L2
▪ Nucleus: oval to round
L3
▪ Nucleus: no clefting
L3
▪ Nucleoli: rare
L1
▪ Nucleoli: not visible or small
L1
▪ Nucleoli: inconspicuous
L1
▪ Nucleoli: present (often large)
L2
▪ Nucleoli: 1-3 (vesicular)
L3
Chromatin : homogenous
L1
▪ Chromatin : variable
L2
▪ Chromatin : finely stippled
L3
▪ Amount: scanty
L1
▪ Amount: moderately abundant
L2
L3
▪ Amount: moderately abundant
L2
L3
Vacuolation: variable
L1
L2
▪ Vacuolation: often prominent
L3
▪ Basophilia: moderate
L1
▪ Basophilia: variable
L2
▪ Basophilia: intense
L3
▪ Incidence: 15 y/o and below
L1
▪ Incidence: older than 15 y/o (adult)
L2
▪ Incidence: rare
L3
▪ most common (more treatment available)
L1
▪ best prognosis
L1
▪ L3 cytogenic abnormality:
t(8;2;14;22)
▪ worst prognosis
L3
▪ “Burkitt’s lymphoma”
L3
A translocation between [?] appears to mark a type of ALL that can evolve into a myeloid (AML) or monocytic diseases
ch4 and ch11
Neutrophil primary granules
Myeloperoxidase (MPO)
Phospholipids
Sudan Black B (SBB)
Cellular enzyme
Specific Esterase
Non-specific Esterase
Intranuclear enzyme
Terminal Deoxyribonucleotidyl Transferase (TdT)
Glycogen
Periodic Acid Schiff (PAS)
Myeloblasts are strongly positive
Myeloperoxidase (MPO)
Sudan Black B (SBB)
Specific Esterase
Differentiates ALL (-) from ANLL (+)
Myeloperoxidase (MPO)
Sudan Black B (SBB)
Monoblasts are strongly positive (M4, M5)
Non-specific Esterase
Lymphoblasts are positive
Terminal Deoxyribonucleotidyl Transferase (TdT)
PAS
Differentiates ALL (+) from ANLL (-)
Terminal Deoxyribonucleotidyl Transferase (TdT)
Important in identifying blastic transformation of CML
Terminal Deoxyribonucleotidyl Transferase (TdT)
(+) M6 (Erythroleukemia)
Periodic Acid Schiff (PAS)
Differentiates L1 (4+) from L2 (1-2+) of ALL
Periodic Acid Schiff (PAS)
Periodic Acid Schiff (PAS)
▪ L1:
▪ L2:
chunky granules (block-like) in staining (very reactive)
minimal granular appearance
(+) AML-M7
(+) ALL L1-L3
Acid Phosphatase
Early (pro/pre-pre) B-ALL
CD34, CD19, cytoplasmic CD22, TdT
Intermediate (common)
BALL CD34, CD19, CD10, cytoplasmic CD22, TdT
Pre-B ALL
CD34, CD19, cytoplasmic CD22, cytoplasmic m, TdT (variable)
T-ALL
CD2, CD3, CD4, CD5, CD7, CD8, TdT
Immunologic markers
: detects B lymphocytes
Surface immunoglobulin (SIg)
: detects T lymphocytes
Sheep erythrocyte receptor
: +70% of ALL patients
CALLA (common acute lymphoblastic antigen)
NOT present on normal peripheral lymphocytes
CALLA (common acute lymphoblastic antigen)
NOT specific for leukemia (also present on normal BM cells that are positive for TdT and HLA-DR antigen)
CALLA (common acute lymphoblastic antigen)
normal in blast cells/bm; abnormal in the circ
CALLA (common acute lymphoblastic antigen)
▪ present on the leukemia cells of 70% of ALL patients
CALLA
▪ not present on normal peripheral lymphocytes
MONOCLONAL COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN (CALLA)
NOT specific for leukemia because it is also present on normal BM cells that are positive for TdT and HLA-DR antigen
MONOCLONAL COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN (CALLA)
CLASSIFICATION BASED ON IMMUNOLOGIC + CYTOCHEMICAL PROPERTIES
▪ absence of T antigens, SIg, and CALLA
Null/Unclassified ALL
▪ presence of CALLA, HLA-DR, and TdT
Common ALL (cALL)
▪ highest remission rate even after chemotherapy
Common ALL (cALL)
• due the appearance of a tumor chromosome identical to Ph1 chromosome (presence makes poor prognosis)
Common ALL (cALL)
▪ T-cell antigen and sheep erythrocyte receptor
T ALL
▪ usually occurs in males
T ALL
▪ CNS involvement
T ALL
▪ poorer prognosis
T ALL
▪ T-cell antigen without sheep erythrocyte receptor
Pre-T ALL
▪ presence of cytoplasmic immunoglobulin (CIg)
Pre-B ALL
▪ absence of SIg
Pre-B ALL
▪ presence of CIg, SIg, and B cell antigen
B ALL
▪ corresponds to FAB L3 classification
B ALL
: present in all ALL types except B ALL
TdT